Johnson & Johnson (NYSE:JNJ) is pursuing an acquisition of Auris Health, Inc. in a deal that would bring it cutting-edge surgical robotics technology, people with knowledge of the matter said. J&J is seeking to purchase Auris at a premium to the valuation from its latest funding round, according to the people, who asked not to be identified because the information is private. No final agreements have been reached, and there’s no certainty the deliberations will lead to a sale of Auris, the people said. Representatives for J&J and Auris declined to comment.